Headline: ANAVEX®3-71 treatment prevents cognitive impairment, reduces amyloid, and neuroinflammation even after a long drug washout
ANAVEX®3-71 halts neurodegeneration and prevents cognitive decline in a transgenic Alzheimer’s disease model
(1)
(0)
Anavex Life Sciences Corp. (AVXL) Stock Research Links
-
-
-
-
-
-
-